Immunobiology of mucosal HIV-1 infection

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 1199-1211

  Smith, Phillip D ^a,b   Wahl, Sharon W ^c  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750620225     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50071-1     Document Type: Chapter

References (110)

1. Alfsen A., Iniguez P., Bouguyon E., Bomsel M. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J. Immunol. 2001, 166:6257-6265.
2. Alfsen A., Bomsel M. HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactoxyl ceramide. J. Bio. Chem. 2002, 277:25649-25659.
3. Amerongen H.M., Weltzin R., Farnet C.M., Michetti P., Haseltine W.A., Neutra M.R. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J. Acquir. Immun. Defic. Syndr. 1991, 4:760-765.
4. Baribaud F., Pohlmann S., Doms R.W. The role of DC-SIGN and DC-SIGNR in HVI and SIV attachment, infection, and transmission. Virology 2001, 286:1-6.
5. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Ann. Rev. Immunol. 1999, 17:657-700.
6. Boirivant M., Viora M., Giordani L., Luzzati A.L., Pronio A.M., Montesani C., Pugliese O. HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis. J. Clin. Immunol. 1998, 18:39-47.
7. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 1997, 3:42-47.
8. Bomsel M., Alfsen A. Entry of viruses through the epithelial barrier: pathogenic trickery. Nat. Rev. Mol. Cell Biol. 2003, 4:57-68.
9. Brandtzaeg P. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 1989, 146:13-25.
10. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 1992, 89:6580-6584.
11. Burgio V.T., Fais S., Boirivant M., Perrone A., Pallone F. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995, 109:1029-1038.
12. + T cells. Science 1992, 257:383-387.
13. Cavert W., Notermans D.W., Staskus K., Wietgrete S.W., Zupancic M., Gebhard K., Henry K., Zhang Z.-Q., Mills R., McDade H., Goudsmit J., Danner S.A., Haase A.T. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
14. Clayton F., Snow G., Reka S., Kotler D.P. Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin. Exp. Immunol. 1997, 107:288-292.
15. + T cells [see comments]. Science 1995, 270:1811-1815.
16. Daar E.S., Moudgil T., Meyer R.D., Ho D.D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Eng. J. Med. 1991, 324:961-964.
17. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Viahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a delection allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273:1856-1862.
18. Del Corno M., Liu Q.H., Schols D., de Clercq E., Gessani S., Freedman B.D., Collman R.G. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 2001, 98:2909-2916.
19. Dobrescu D., Ursea B., Pope M., Asch A.S., Posnett D.N. Enhanced HIV-1 replication in Vβ12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen. Cell 1995, 82:753-763.
20. Fantini J., Cook D.G., Nathanson N., Spitalnik S.L., Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA 1993, 90:2700-2704.
21. Fleming D.T., Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 1999, 75:3-17.
22. Fotopoulos G., Harari A., Michetti P., Trono D., Pantaleo G., Kraehenbuhl J.P Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc. Natl. Acad. Sci. USA 2002, 99:9410-9414.
23. Fox C.H., Kotler D.P., Tierney A.R., Wilson C.S., Fauci A.S. Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. J. Infect. Dis. 1989, 159:467-471.
24. Frankel S.S., Wenig B.M., Burke A.P., Mannan P., Thompson L.D.R., Abbondanzo S.L., Nelson A.M., Pope M., Steinman R.M. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996, 272:115-117.
25. Frankel S.S., Steinman R.M., Michael N.L., Kim S.R., Bhardwaj N., Pope M., Louder M.K., Ehrenberg P.K., Parren P.W., Burton D.R., Katinger H., VanCott T.C., Robb M.L., Birx D.L., Mascola J.R. Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cell. J. Virol. 1998, 72:9788-9794.
26. Geijtenbeek T.B.H., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C.F., Middel J., Cornelissen I.L.M.H.A., Nottet H.S.L.M., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:491-494.
27. Granelli-Piperno A., Delgado E., Finkel V., Paxton W., Steinman R.M. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 1998, 72:2733-2737.
28. Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X, vanCott T., Quinn T.C., Rakai Project Team Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149-1153.
29. Greenwell-Wild T., Vazquez N., Sim D., Schito M., Chatterjee D., Orenstein J.M., Wahl S.M. Mycobacterium avium infection and modulation of human macrophage gene expression. J. Immunol. 2002, 169:6286-6297.
30. Grimm M.C., Pullman W.E., Benner G.M., Sullivan P.J., Pavli P., Doe W.F. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hep. 1995, 10:387-395.
31. +-T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003, 77:11708-11717.
32. Haase A.T., Henry K., Zupancic M., Sedgewick G., Faust R.A., Melroe H., Cavert W., Gebhard K., Staskus K., Zhang Z.Q., Dailey P.J., Balfour H.H., Erice A., Perelson A.S. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996, 274:985-990.
33. Haase A.T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Ann. Rev. Immunol. 1999, 17:625-656.
34. Hale-Donze H., Greenwell-Wild T., Mizel D., Doherty T.M., Chatterjee D., Orenstein J.M., Wahl S.M. Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria. J. Immunol. 2002, 169:3854-3862.
35. Harriman G.R., Smith P.D., Horne M.K., Fox C.H., Koenig S., Lack E.E., Lane H.C., Fauci A.S. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 1989, 149:2039-2041.
36. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [see comments]. Nat. Med. 1996, 2:1240-1243.
37. + T cells results in altered cytokine production, activation threshold, and costimulatory requirements. J. Immunol. 1999, 163:5937-5945.
38. + T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. USA 2001, 98:658-663.
39. Janoff E.N., Smith P.D. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology 2001, 120:607-621.
40. Jassoy C., Walker B.D. HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication. Springer Semin. Immunopathol. 1997, 18:341-354.
41. Kewenig S., Schneider T., Hohloch K., Lampe-Dreyer K., Ullrich R., Stolte N., Stahl-Hennig C., Kaup F.J., Stallmach A., Zeitz M. Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 1999, 116:1115-1123.
42. Kinloch-de Loes S., Hirschel B.J., Hoen B., Cooper D.A., Tindall B., Carr A., Saurat J.H., Clumeck N., Lazzarin A., Mathiesen L., et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N. Engl. J. Med. 1995, 333:408-413.
43. Kotler D.P., Reka S., Clayton F. Intestinal mucosal inflammation associated with human immunodeficiency virus infection. Dig. Dis. Sci. 1993, 38:1119-1127.
44. Kotler D.P., Shimada T., Snow G., Winson G., Chen W., Zhao M., Inada Y., Clayton F. Effect of combination anti-retroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS 1998, 12:597-604.
45. Lawn S.D., Subbarao S., Wright J.T.C., Evans-Strickfaden T., Ellerbrock T.V., Lennox J.L., Butera S.T., Hart C.E. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J. Infect. Dis. 2000, 181:1950-1956.
46. Lee S.H., Starkey P.M., Gordon S. Quantitative analysis of total macrophage content in adult mouse tissues: immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 1984, 161:475-489.
47. Li L., Meng G., Graham M.F., Shaw G.M., Smith P.D. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. Gastroenterology 1999, 116:1043-1053.
48. Lifson J.D., Reyes G.R., McGrath M.S., Stein B.S., Engleman E.G. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1988, 232:1123-1127.
49. Maayan S., Soskolne V., Engelhard D., Moses A., Rahav G., Raveh D., Newman D., Weinberger M. Sexual behavior of homosexual and bisexual men attending an HIV testing clinic in Jerusalem 1986/7-1990. Isr. J. Psych. Rel. Sci. 1993, 30:150-154.
50. Maric I., Holt P.G., Perdue M.H., Bienenstock J. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J. Immunol. 1996, 156:1408-1414.
51. + T-cell depletion in primary simian immunodeficiency virus infection. J. Virol. 1998, 72:6421-6429.
52. McDonald D., Wu L., Bohks S.M., KewalRamani V.N., Unutmaz D., Hope T.J. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003, 300:1295-1298.
53. McGowan I., Radford-Smith G., Jewell D.P. Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994, 8:1569-1575.
54. McNearey T., Hornickova Z., Markham R., Birdwell A., Arens M., Saah A., Ratner L. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA 1992, 89:10247-10251.
55. McNeely T.B., Dealy M., Dripps D.J., Orenstein J.M., Eisenberg S.P., Wahl S.M. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 1995, 96:456-464.
56. Mellors J.W., Rinaldo C.R.J., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
57. Meng G., Sellers M., Mosteller-Barnum M., Rogers T., Shaw G., Smith P.D. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are likely target cell for HIV-1 in the intestinal mucosa. J. Infect. Dis. 2000, 182:785-791.
58. + cells. Nat. Med. 2002, 8:150-156.
59. Orenstein J.M., Meltzer M.S., Phipps T., Gendelman H.E. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J. Virol. 1988, 62:2578-2586.
60. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861.
61. Page-Shafer K., Shiboski C.H., Osmond D.H., Dilley J., McFarland W., Shiboski S.C., Klausner J.D., Balls J., Greenspan D., Greenspan J.S. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS 2002, 16:2350-2352.
62. Pavli P., Hume D.A., Van De Pol E., Doe W.F. Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology 1993, 78:132-141.
63. + mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J. Virol. 2001, 75:8390-8399.
64. Pope M. Mucosal dendritic cells and immunodeficiency viruses. J. Infect. Dis. 1999, 179:S427-S430.
65. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., Meehan M., Lutalo T., Gray R. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 2000, 342:921-929.
66. Reka S., Garro M.L., Kotler D.P. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection. Lymphokine Cytok. Res. 1994, 13:391-398.
67. Royce R.A., Sena A., Cates W.J., Cohen M.S. Sexual transmission of HIV. N. Engl. J. Med. 1997, 336:1072-1078.
68. Rugtveit J., Brandtzaeg P., Halstensen T.S., Fausa O., Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994, 35:669-674.
69. Schacker T., Collier A.C., Hughes J., Shea T., Corey L. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 1996, 125:257-264.
70. Schacker T., Little S., Connick E., Gebhard K., Zhang Z.-Q., Krieger J., Pryor J., Havlir D., Wong J.K., Schooley R.T., Richman D., Corey L., Haase A.T. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis. 2001, 183:555-562.
71. Schieferdecker H.L., Ullrich R., Hirseland H., Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J. Immunol. 1992, 149:2816-2822.
72. Schmidtmayerova H., Nottet H.S.L.M., Nuovo G., Raabe T., Flanagan C.R., Dubrovsky L., Gendelman H.E., Cerami A., Bukrinsky M., Sherry B. Human immunodeficiency virus type 1 infection alters chemokine b peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 1996, 93:700-704.
73. Schneider T., Ullrich R., Bergs C., Schmidt W., Riecken E.O., Zeitz M. Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. Clin. Exp. Immunol. 1994, 95:430-435.
74. Schneider T., Jahn H.U., Schmidt W., Riecken E.O., Zeitz M., Ullrich R. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut 1995, 37:524-529.
75. Schwarcz S.K., Kellogg T.A., Kohn R.P., Katz M.H., Lemp G.F., Bolan G.A. Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992. Am. J. Epidemiol. 1995, 142:314-322.
76. Shacklett B.L., Beadle T.J., Pacheco P.A., Grendell J.H., Haslett P.A.J., King A.S., Ogg G.S., Basuk P.M., Nixon D.F. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology 2000, 279:317-321.
77. Skolnik P.R., Kosloff B.R., Hirsch M.S. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J. Infect. Dis. 1988, 157:508-514.
78. Smith P.D., Saini S.S., Raffeld M., Manischewitz J.F., Wahl S.M. Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J. Clin. Invest. 1992, 90:1642-1648.
79. Smith P.D., Eisner M.S., Manischewitz J.F., Gill V.J., Masur H., Fox C.F. Esophageal disease in AIDS is associated with pathologic processes rather than mucosal human immunodeficiency virus type 1. J. Infect. Dis. 1993, 167:547-552.
80. Smith P.D., Fox C.H., Masur H., Winter H.S., Alling D.W. Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J. Exp. Med. 1994, 180:1541-1546.
81. Smith P.D., Janoff E.N., Mosteller-Barnum M., Merger M., Orenstein J.M., Kearney J.F., Graham M.F. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J. Immunol. Meth. 1997, 202:1-11.
82. Smith P.D., Meng G., Shaw G.M., Li L. Infection of gastrointestinal tract macrophages by HIV-1. J. Leuk. Biol. 1997, 62:72-77.
83. Smith P.D., Meng G., Sellers M.T., Rogers T.S., Shaw G.M. Biological parameters of HIV-1 infection in primary intestinal lymphocytes and macrophages. J. Leuk. Biol. 2000, 68:360-365.
84. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., Graham M.F., Shimada T., Kubagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 2001, 167:2651-2656.
85. Smith P.D., Janoff E.N. Gastrointestinal infections in HIV-1 disease. Infections of the Gastrointestinal Tract 2002, 415-443. Lippincott-Raven Publishers, Philadelphia. M.J. Blaser (Ed.).
86. Smith P.D., Meng G., Salazar-Gonzalez J.F., Shaw G.M. Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leuk. Biol. 2003, In press.
87. + T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 1998, 72:6646-6656.
88. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., Benjamin W.H., Orenstein J.M., Smith P.D. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 2004, In revision.
89. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 1996, 183:215-225.
90. Stahl-Hennig C., Steinman R.M., Tenner-Racz K., Pope M., Stolte N., Matz-Rensing K., Grobschupff G., Raschdorff B., Hunsmann G., Racz P. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 1999, 285:1261-1265.
91. Telzak E.E., Chiasson M.A., Bevier P.J., Stoneburner R.L., Castro K.G., Jaffe H.W. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann. Intern. Med. 1993, 119:1181-1186.
92. - dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 2003, 33:143-151.
93. Tsomides T.J., Aldovini A., Johnson R.P., Walker B.D., Young R.A., Eisen H.N. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 1994, 180:1283-1293.
94. Turville S.G., Cameron P.U., Handley A., Lin G., Pohlmann S., Doms R.W., Cunningham A.L. Diversity of receptors binding HV I on dendritic cell subsets. Nat. Immunol. 2002, 3:975-983.
95. Tyndall M.W., Ronald A.R., Agoki E., Malisa W., Bwayo J.J., Ndinya-Achola J.O., Moses S., Plummer F.A. Increased risk of infection with human immunodeficiency virus type 1 among uncircumcised men presenting with genital ulcer disease in Kenya. Clin. Infect. Dis. 1996, 23:449-453.
96. Ullrich R., Zeitz M., Heise W., L'age M., Hoffken G., Riecker E.O. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): Evidence for HIV-induced enteropathy. Ann. Intern. Med. 1989, 3:15-21.
97. Vázquez N., Greenwell-Wild T., Marinos N.J., Swaim W.D., Nares S., Orenstein J.M., Sporn M.B., Wahl S.M. HIV-1 induced macrophage gene expression includes CDKN1A/p21, a potential host cell target for viral regulation 2003, Submitted.
98. + T cell depletion and viral replication in SIV infection. Science 1998, 280:427-431.
99. Vicenzi E., Alfano M., Ghezzi S., Gatti A., Veglia F., Lazzarin A., Sozzani S., Mantovani A., Poli G. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1α, and MCP-3, and enhancement by MCP-1. J. Leuk. Biol. 2000, 68:405-412.
100. Vittinghoff E., Douglas J., Judson F., McKirnan D., MacQueen K., Buchbinder S.P. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am. J. Epidemiol. 1999, 150:306-311.
101. Wahl S.M., Orenstein J.M., Smith P.D. Macrophage function in HIV-1 infection. Immunology of Human Immunodeficiency Virus Type 1 Infection 1996, 303-336. Plenum Press, New York. S.D. Gupta (Ed.).
102. Wahl S.M., Greenwell-Wild T., Peng G., Hale-Donze H., Doherty T.M., Mizel D., Orenstein J.M. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc. Natl. Acad. Sci. USA 1998, 95:12574-12579.
103. Wahl S.M., Smith P.D., Janoff E.N. Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis: comments and conference summary. J. Infect. Dis. 1999, 179:S397-S400.
104. Wahl S.M., Greenwell-Wild T., Peng G., Ma G., Orentstin J.M., Vazquez N. Viral and host cofactors facilitate HIV-1 replication in macrophages. J. Leuk. Biol. 2003, 174:26-33.
105. Wolinsky S.M., Wike C.M., Korber B.T.M., Hutto C., Parks W.P., Rosenblum L.L., Kunstman K.J., Furtado M.R., Munoz J.L. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255:1134-1136.
106. Wu L., Bashirova A.A., Martin T.D., Villamide L., Mehlhop E., Chertov A.O., Unutmaz D., Pope M., Carrington M., KewalRamani V.N. Rhesus macaque dendritic cells efficiently transmit primate lentivuruses independently of DC-SIGN. Proc. Natl. Acad. Sci. USA 2002, 99:1568-1573.
107. Yolffe B., Lewis D.E., Petrie B.L., Noonan C.A., Melnick J.L., Hollinger F.B. Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1987, 84:1429-1433.
108. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., Chen I.S.Y. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61:213-222.
109. + T cells. Science 1999, 286:1353-1357.
110. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., Ho D.D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993, 261:1179-1181.